We are live on ! Find out more
JGUA

John G. Ullman & Associates Portfolio holdings

AUM $754M
1-Year Est. Return 60.05%
This Fund
S&P 500
This Quarter Est. Return
-3.12%
1 Year Est. Return
+60.05%
3 Year Est. Return
+108.28%
5 Year Est. Return
+118.76%
10 Year Est. Return
+308.24%
AUM
$735M
AUM Growth
-$32.3M
Cap. Flow
-$7.57M
Cap. Flow %
-1.03%
Top 10 Hldgs %
32.72%
Holding
167
New
11
Increased
20
Reduced
93
Closed
7

Top Sells

Rank Stock Value
1
JNJ icon
Johnson & Johnson
JNJ
+$14.7M
2
GSK icon
GSK
GSK
+$5.1M
3
ALB icon
Albemarle
ALB
+$4.22M
4
PGJ icon
Invesco Golden Dragon China ETF
PGJ
+$2.39M
5
XRX icon
Xerox
XRX
+$1.4M

Sector Composition

Rank Sector Weight
1 Technology 24.04%
2 Healthcare 21.31%
3 Industrials 18.46%
4 Utilities 17.61%
5 Communication Services 8.99%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
ABT icon
51
Abbott
ABT
$185B
$3.74M 0.51%
31,638
-300
-0.9% -$36.9K
AGR
52
DELISTED
Avangrid, Inc.
AGR
$3.64M 0.5%
74,950
-450
-0.6% -$23.7K
A icon
53
Agilent Technologies
A
$39.5B
$3.63M 0.49%
23,052
-700
-3% -$113K
VOO icon
54
Vanguard S&P 500 ETF
VOO
$1.01T
$3.25M 0.44%
8,230
+1,928
+31% +$782K
SYNA icon
55
Synaptics
SYNA
$4.01B
$3.2M 0.44%
17,800
-400
-2% -$67.3K
CCK icon
56
Crown Holdings
CCK
$13.2B
$3.08M 0.42%
30,604
-400
-1% -$42K
COHR icon
57
Coherent
COHR
$66.8B
$3.07M 0.42%
51,750
+35,350
+216% +$2.31M
PEG icon
58
Public Service Enterprise Group
PEG
$37.5B
$3.04M 0.41%
49,910
AMT icon
59
American Tower
AMT
$79.8B
$3M 0.41%
11,320
-150
-1% -$42.8K
GRC icon
60
Gorman-Rupp
GRC
$2.24B
$2.96M 0.4%
82,789
-699
-0.8% -$24.8K
UCTT
61
Ultra Clean Holdings
UCTT
$3.77B
$2.91M 0.4%
+68,404
New +$3.23M
AAPL icon
62
Apple
AAPL
$4.54T
$2.75M 0.37%
19,410
+200
+1% +$29.4K
VWO icon
63
Vanguard FTSE Emerging Markets ETF
VWO
$123B
$2.71M 0.37%
54,119
+34,700
+179% +$1.79M
ASTE icon
64
Astec Industries
ASTE
$1.04B
$2.68M 0.36%
49,730
-900
-2% -$53.1K
EEMV icon
65
iShares MSCI Emerging Markets Min Vol Factor ETF
EEMV
$3.53B
$2.66M 0.36%
42,500
+26,400
+164% +$1.66M
ETN icon
66
Eaton
ETN
$175B
$2.66M 0.36%
17,800
-400
-2% -$63.9K
OCDX
67
DELISTED
Ortho Clinical Diagnostics Holdings plc Ordinary Shares
OCDX
$2.26M 0.31%
+122,519
New +$2.47M
XRX icon
68
Xerox
XRX
$427M
$2.25M 0.31%
111,666
-61,734
-36% -$1.4M
TT icon
69
Trane Technologies
TT
$106B
$2.18M 0.3%
12,650
-200
-2% -$38.5K
MCFE
70
DELISTED
McAfee Corp. Class A Common Stock
MCFE
$2.11M 0.29%
95,500
+52,100
+120% +$1.35M
PHG icon
71
Philips
PHG
$25.7B
$1.83M 0.25%
49,890
-1,007
-2% -$38.3K
GE icon
72
GE Aerospace
GE
$390B
$1.83M 0.25%
28,489
-1,450
-5% -$93.2K
BE icon
73
Bloom Energy
BE
$69.7B
$1.81M 0.25%
+96,700
New +$2.05M
RBB icon
74
RBB Bancorp
RBB
$456M
$1.76M 0.24%
69,750
-700
-1% -$17.2K
BAX icon
75
Baxter International
BAX
$14.1B
$1.74M 0.24%
21,677
+7,067
+48% +$558K

Similar funds

John G. Ullman & Associates's Q3 2021 Portfolio in Review

As of Q3 2021, John G. Ullman & Associates held 167 positions worth $735M, down 4.2% from $768M the previous quarter. Its ten largest holdings account for 33% of the portfolio.

John G. Ullman & Associates's Q3 2021 filing shows 11 new, 20 increased, 93 reduced and 7 closed positions. Its largest new stake was Ultra Clean Holdings: 68,404 shares worth $2.91M. The largest sale was Johnson & Johnson, an estimated $14.7M.

By sector, the portfolio is most concentrated in Technology at 24% of assets, up from 23% a quarter earlier, followed by Healthcare and Industrials.

  • John G. Ullman & Associates's largest Q3 2021 buy was Ultra Clean Holdings: 68,404 shares worth $2.91M.
  • John G. Ullman & Associates added most to Itron in Q3 2021, an estimated $3.82M increase.
  • John G. Ullman & Associates's biggest Q3 2021 reduction was Johnson & Johnson, cutting an estimated $14.7M.
  • John G. Ullman & Associates fully exited Albemarle in Q3 2021, selling an estimated $4.22M.
  • John G. Ullman & Associates's ten largest holdings make up 33% of its $735M portfolio in Q3 2021.
  • John G. Ullman & Associates opened 11 new positions and closed 7 in Q3 2021.
  • John G. Ullman & Associates's portfolio value fell 4.2% quarter-over-quarter to $735M.

Based on John G. Ullman & Associates's 13F filing for Q3 2021, filed 2 Nov 2021.